Scientist

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Laronde

Scientist, Assay Development

Scientist, Immuno-oncology

Scientist, Combinatorial Chemistry

Scientist I/II, Biomolecule Production

Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits.

Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones. They work with clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.

Kingdom Supercultures

Looking for another scientific role?

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

Kernal creates mRNA therapies to cure diseases like COVID and cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. Kernal won three awards from Amgen and NASA. With roots at MIT, Harvard and Big Pharma, the team previously built a successful Biotech company and has deep expertise in mRNA space.

Kernal Biologics

Scientist I/II: in vivo Pharmacology / Immuno-Oncology

A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.

Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bioâ€™s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agricultureâ€™s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.

Joyn Bio

Scientist, High Content Imaging

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.

Intellia Therapeutics

Scientist, Preclinical NGS

Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.

Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment. It embraces diversity in every aspect of its business to drive innovation and help build a new food system. The company's technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of the seed. Inari's SEEDesign platform is their point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach. It was founded in 2016 and is based in Cambridge, MA.

Inari

Scientist, Phenomics

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.

HilleVax

Scientist II, Analytical Development

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Its platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. The company was founded in 2021 and is headquartered Cambridge, Massachusetts.

Garuda Therapeutics

In Vivo Scientist

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie's radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads.

Curie Therapeutics

Scientist, CMC Radiochemistry

CrownBio is helping provide clarity of action in the fight against cancer and diabetes.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

Location

Company Stage

Age of Data

Experience

Industry

Company